Repositório Digital

A- A A+

Cost-effectiveness of a national population‑based screening program for type 2 diabetes : the Brazil experience

.

Cost-effectiveness of a national population‑based screening program for type 2 diabetes : the Brazil experience

Mostrar registro completo

Estatísticas

Título Cost-effectiveness of a national population‑based screening program for type 2 diabetes : the Brazil experience
Autor Toscano, Cristiana M.
Zhuo, Xiaohui
Imai, Kumiko
Duncan, Bruce Bartholow
Polanczyk, Carisi Anne
Zhang, Ping
Engelgau, Michael
Schmidt, Maria Inês
Abstract Background: The cost-effectiveness of screening for type 2 diabetes mellitus (DM2) in developing countries remains unknown. The Brazilian government conducted a nationwide population screening program for type 2 diabetes mellitus (BNDSP) in which 22 million capillary glucose tests were performed in individuals aged 40 years and older. The objective of this study was to evaluate the life-time cost-effectiveness of a national population-based screening program for DM2 conducted in Brazil. Methods: We used a Markov-based cost-effectiveness model to simulate the long-term costs and benefits of screening for DM2, compared to no screening program. The analysis was conducted from a public health care system perspective. Sensitivity analyses were conducted to examine the robustness of results to key model parameters. Results: Brazilian National diabetes screening program will yield a large health benefit and higher costs. Compared with no screening, screen detection of undiagnosed diabetes resulted in US$ 31,147 per QALY gained. Results from sensitivity analyses found that screening targeted at hypertensive individuals would cost US$ 22,695/QALY. When benefits from early glycemic control on cardiovascular outcomes were considered, the cost per QALY gained would reduce significantly. Conclusions: In the base case analysis, not considering the intangible benefit of transferring diabetes management to primary care nor the benefit of using statin to treat eligible diabetic patients, CE ratios were not cost-effective considering thresholds proposed by the World Health Organization. However, significant uncertainty was demonstrated in sensitivity analysis. Our results indicate that policy-makers should carefully balance the benefit and cost of the program while considering using a population-based approach to screen for diabetes.
Contido em Diabetology and Metabolic Syndrome. [London]. Vol. 7, n. 95 (2015), 11 p.
Assunto Análise custo-eficiência
Diabetes mellitus tipo 2
Origem Estrangeiro
Tipo Artigo de periódico
URI http://hdl.handle.net/10183/148808
Arquivos Descrição Formato
000998327.pdf (981.8Kb) Texto completo (inglês) Adobe PDF Visualizar/abrir

Este item está licenciado na Creative Commons License

Este item aparece na(s) seguinte(s) coleção(ões)


Mostrar registro completo

Percorrer



  • O autor é titular dos direitos autorais dos documentos disponíveis neste repositório e é vedada, nos termos da lei, a comercialização de qualquer espécie sem sua autorização prévia.
    Projeto gráfico elaborado pelo Caixola - Clube de Criação Fabico/UFRGS Powered by DSpace software, Version 1.8.1.